1. Angiogenesis following Cell Injection is Induced by an Excess Inflammatory Response Coordinated by Bone Marrow Cells
- Author
-
Hidemi Hattori Ph.D., Yoshiko Amano, Yoshiko Habu-Ogawa, Takahiro Ando, Bonpei Takase, and Masayuki Ishihara
- Subjects
Medicine - Abstract
The aim of this study was to identify novel angiogenic mechanisms underlying the regenerative process. To that end, interactions between adipose tissue-derived stromal cells (ASCs) and bone marrow cells (BMCs) were initially investigated using real-time fluorescence optical imaging. To monitor cell behavior in mice, we injected green fluorescent protein-positive (GFP + ) BMCs into the tail vein and injected PKH26-labeled ASCs behind the ears. Angiogenesis and inflammation were observed at these sites via an optical imaging probe. Injected GFP + BMCs migrated from the blood vessels into the tissues surrounding the ASC injection sites. Many of the migrating GFP + BMCs discovered at the ASC injection sites were inflammatory cells, including Gr-1 + , CD11b + , and F4/80 + cells. ASCs cocultured with inflammatory cells secreted increased levels of chemokines such as macrophage inflammatory protein (MIP)-1α, MIP-1β, keratinocyte-derived chemokines, and monocyte chemotactic protein 1. Similarly, these ASCs secreted increased levels of angiogenic growth factors such as hepatocyte growth factor and vascular endothelial growth factor. However, when anti-CXC chemokine receptor type 4 antibody was injected at regular intervals, the migration of GFP + BMCs (especially Gr-1 + and CD11b + cells) to ASC injection sites was inhibited, as was angiogenesis. The collective influence of the injected ASCs and BMC-derived inflammatory cells promoted acute inflammation and angiogenesis. Together, the results suggest that the outcome of cell-based angiogenic therapy is influenced not only by the injected cells but also by the effect of intrinsic inflammatory cells.
- Published
- 2013
- Full Text
- View/download PDF